Testicular Cancer Monitor Profile
Use
Monitor the course of testicular cancer, patient response to treatment, and disease recurrence
Special Instructions
To ensure consistent and reliable results, it is recommended that only one assay method be used throughout the course of monitoring for a patient. It is important that the testing account submits the patient's Social Security number for monitoring. It is also crucial to note that different assay methods should not be used interchangeably in serial testing.
Limitations
This profile is not suitable as a diagnostic or screening test for cancer. Assay values obtained with different methods cannot be used interchangeably, and test results should not be interpreted as absolute evidence of the presence or absence of malignant disease. Additionally, the test is not interpretable for pregnant females as a tumor marker. The test was developed by LabCorp and has not been cleared or approved by the FDA for use as a tumor marker.
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 45194-8
- 53962-7
- 53962-7
- 45194-8
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
1 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
If a red-top tube is used, transfer separated serum to a plastic transport tube.
Storage Instructions
Refrigerate
Causes for Rejection
Gross hemolysis; whole blood specimen
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant